Whalesbook
Q4FY26 Strength Meets Sectoral Caution
UltraTech Cement delivered a powerful fiscal fourth quarter, showcasing impressive operational execution that translated into an EBITDA beating analyst expectations by 13%. The company achieved an all-time quarterly high in PBIDT, reaching ₹5,688 crore, a 20% year-on-year surge, with operating PBIDT per tonne ascending to ₹1,253. This robust performance was underpinned by strong volume growth, with India's grey cement sales volumes reaching 42.41 million tonnes, up 9.3% year-on-year. Total revenue for the quarter advanced 12% to ₹25,467 crore. The company capped off the quarter by announcing a record dividend payout of ₹240 per share, significantly higher than the ₹77.5 distributed the previous year, indicating strong cash flow generation and a commitment to shareholder returns. As of April 29, 2026, the stock was trading around ₹11,833, reflecting market acknowledgement of its operational prowess.
The Valuation Premium Amidst Industry Overcapacity
While UltraTech Cement’s individual performance shines, the broader industry context presents a more challenging outlook. Analysts are voicing concerns over a significant increase in competitive intensity, driven by substantial capacity additions slated across the sector. Projections indicate an addition of 160-170 million metric tons of grinding capacity between fiscal years 2026 and 2028, a 75% jump from the previous three fiscal years. This aggressive expansion, coupled with fluctuating fuel costs, poses a direct threat to future profitability and margin stability. Peers like Ambuja Cement trade at a P/E ratio of approximately 27.7x TTM, while Shree Cement hovers around 51.93x TTM. UltraTech Cement's own P/E ratio stands around 42.70x, placing it at a premium valuation, which may be difficult to sustain if sector-wide pricing pressures intensify.
The Bear Case: Margin Compression and Debt Load
The primary risk for UltraTech Cement lies in the potential for margin compression stemming from increased competition and oversupply. The substantial capacity additions across the industry could lead to price wars, eroding profitability despite strong demand drivers like government infrastructure spending. Furthermore, while UltraTech Cement's Net Debt-to-EBITDA improved to a healthy 0.94x as of March 31, 2026, it is notably higher than competitors like Ambuja Cement, which is virtually debt-free. The volatility of crude oil prices, a key input cost, presents an ongoing challenge that the company is attempting to mitigate through price adjustments implemented in early April. Analyst reports have flagged these risks, with some maintaining a 'Hold' rating due to these sector-specific concerns, despite acknowledging the company's strong execution. The stock has also seen a minor year-on-year decline, trading down approximately 1.3% over the past year.
Outlook and Analyst Consensus
Despite the acknowledged sectoral headwinds, many analysts maintain a positive stance on UltraTech Cement's long-term prospects, driven by its market leadership and expansion plans. Brokerages like Jefferies and HSBC maintain 'Buy' ratings with price targets around ₹14,050 and ₹14,200 respectively. Nomura has a target of ₹13,900, citing earnings surprises driven by better realisations. The consensus among 38 analysts points towards a 'Strong Buy' rating, with an average 12-month price target of approximately ₹13,636.79, implying a potential upside. The company’s strategy includes significant capital expenditure over the next three years to expand consolidated capacity beyond 240 MTPA. Management is targeting double-digit year-on-year volume growth in FY27, outpacing the industry estimate of 7-8%.